Bioavailability of Apigenin from Apiin-Rich Parsley in HumansMeyer H.a · Bolarinwa A.a · Wolfram G.b · Linseisen J.a, c
aUnit of Human Nutrition and Cancer Prevention and bDepartment of Food and Nutrition, Technical University of Munich, Freising-Weihenstephan, and cDivision of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Aim: Absorption and excretion of apigenin after the ingestion of apiin-rich food, i.e. parsley, was tested. Methods: Eleven healthy subjects (5 women, 6 men) in the age range of 23–41 years and with an average body mass index of 23.9 ± 4.1 kg/m2 took part in this study. After an apigenin- and luteolin-free diet, a single oral bolus of 2 g blanched parsley (corresponding to 65.8 ± 15.5 µmol apigenin) per kilogram body weight was consumed. Blood samples were taken at 0, 4, 6, 7, 8, 9, 10, 11 and 28 h after parsley consumption and 24-hour urine samples were collected. Apigenin was analyzed in plasma, urine and red blood cells by means of HPLC-ECD. Results: On average, a maximum apigenin plasma concentration of 127 ± 81 nmol/l was reached after 7.2 ± 1.3 h with a high range of variation between subjects. For all participants, plasma apigenin concentration rose after bolus ingestion and fell within 28 h under the detection limit (2.3 nmol/l). The average apigenin content in 24-hour urine was 144 ± 110 nmol/24 h corresponding to 0.22 ± 0.16% of the ingested dose. The flavone could be detected in red blood cells without showing dose-response characteristics. Conclusions: A small portion of apigenin provided by food reaches the human circulation and, therefore, may reveal biological effects.
© 2006 S. Karger AG, Basel
- Birt DF, Hendrich S, Wang W: Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90:157–177.
- Hollman PCH, Arts ICW: Flavonols, flavones and flavanols – nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1081–1093.
- Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L: Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727–747.
- Hirvonen T, Törnwall ME, Pietinen P, Korhonen P, Albanes D, Virtamo J: Flavonol and flavone intake and the risk of intermittent claudication in male smokers. Eur J Epidemiol 2004;19:305–311.
Lugasi A, Hóvári J, Sági KV, Bíró L: The role of antioxidant phytonutrients in the prevention of diseases. Acta Biol Szeged 2003;47:119–125.
Van Dross R, Xue Y, Knudson A, Pelling JC: The chemopreventive bioflavonoid apigenin modulates signal transduction pathway in keratinocyte and colon carcinoma cell lines. J Nutr 2003;133:3800S–3804S.
- Wei H, Tye L, Bresnick E, Birt DF: Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990;50:499–502.
- Way T, Kao M, Lin J: Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 2004;279:4479–4489.
- Shukla S, Gupta S: Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol Carcinog 2004;39:114–126.
- Gradolatto A, Canivier MC, Basly JP: Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver. Drug Metab Dispos 2004;32:58–65.
Janssen K, Mensink RP, Cox FJJ, Harryvan JL, Hovenier R, Hollman PCH, Katan MB: Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;97:255–262.
- Nielsen SE, Young JF, Daneshvar B, Lauridsen ST, Knuthsen P, Sandström B, Dragsted LO: Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr 1999;81:447–455.
- Bolarinwa A, Linseisen J: Validated application of a new high-performance liquid chromatographic method for the determination of selected flavonoids and phenolic acids in human plasma using electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 2005;823:143–151.
- Ortmann R, Sandermann H, Grisebach H: Transfer of apiose from UDP-apiose to 7-O- (β-D-glycosyl)apigenin and 7-O-(β-D-glycosyl)chrysoeriol with an enzyme preparation of parsley. FEBS Lett 1970;7:164–166.
Database for the Flavonoid Content of Selected Foods. USDA http://www.nal.usda.gov/fnic/foodcomp (March 2003).
- Hertog MGL, Hollman PCH, Katan MB: Optimization of a quantitative HPLC determination of potentially anticancerogenic flavonoids in vegetables and fruits. J Agric Food Chem 1992;40:1591–1598.
- Justesen U, Knuthsen P, Leth T: Quantitative analysis of flavonols, flavones and flavanones in friuts, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J Chromatogr A 1998;799:101–110.
- Kreydiyyeh SI, Usta J: Diuretic effect and mechanism of action of parsley. J Ethnopharmacol 2002;79:353–357.
- Nielsen SE, Dragsted LO: Column-switching high-performance liquid chromatographic assay for determination of apigenin and acacetin in human urine with ultraviolet absorbance detection. J Chromatogr A 1998;713:379–386.
- Chen J, Lin H, Hu M: Metabolism of flavonoids via enteric recycling: role of intestinal disposition. Pharmacol Exp Ther 2002;304:1228–1235.
- Pietta P: Flavonoids as antioxidants – review. J Nat Prod 2000;63:1035–1042.
- Fiorani M, Accorsi A, Cantoni O: Human red blood cells as a natural flavonoid reservoir. Free Radic Res 2003;37:1331–1338.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.